Integrated BioPharma Inc. has extended its $4 million revolving loan with PNC Bank. The extension will end April 14, 2027.
Integrated BioPharma also entered a convertible line of credit note (Convertible ELOC) for $250,000, according to a document filed with the Securities and Exchange Commission June 30, 2026. This Convertible ELOC is intended to finance equipment and vehicle purchases.
At the same time, the company matured a $500,000 Convertible Equipment Line with PNC Bank that expired on June 30, 2026.